Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma

被引:92
|
作者
Wang, Wen [1 ]
Zhao, Lan Juan [1 ]
Tan, Ye Xiong [2 ]
Ren, Hao [1 ]
Qi, Zhong-Tian [1 ]
机构
[1] Second Mil Med Univ, Dept Microbiol, Shanghai Key Lab Med Biodef, Shanghai 200433, Peoples R China
[2] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Lab Signal Transduct, Shanghai 200433, Peoples R China
关键词
Hepatocellular carcinoma; miR-138; miR-199a-5p; Cyclin D3; Clathrin heavy chain; Bioinformatics; Taqman array; CLATHRIN HEAVY-CHAIN; TUMOR-SUPPRESSOR; MICRORNA; EXPRESSION; INHIBITION; INVASION; PATHWAY; CELLS; TOOL; PROLIFERATION;
D O I
10.3748/wjg.v18.i38.5442
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To identify the differentially expressed miRNAs and their targets in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC). METHODS: Six hundred and sixty seven human miRNAs were quantitatively analyzed by Taqman low-density miRNA array (TLDA) in HBV-HCC tissues. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were used to analyze the significant function and pathway of the differentially expressed miRNAs in HBV-HCC. TargetScan software was used to predict the targets of deregulated miRNAs. Western blotting and luciferase assay were performed to verify the targets of these miRNAs. RESULTS: Ten up-regulated miRNAs (miR-217, miR-518b, miR-517c, miR-520g, miR-519a, miR-522, miR-518e, miR-525-3p, miR-512-3p, and miR-518a-3p) and 11 down-regulated miRNAs (miR-138, miR-214, miR-214#, miR-199a-5p, miR-433, miR-511, miR-592, miR-483-3p, miR-483-5p, miR-708 and miR-1275) were identified by Taqman miRNAs array and confirmed quantitatively by reverse transcription polymerase chain reaction in HCC and adjacent non-tumor tissues. GO and KEGG pathway analysis revealed that "regulation of actin cytoskeleton" and "pathway in cancer" are most likely to play critical roles in HCC tumorigenesis. MiR-519a and ribosomal protein S6 kinase polypeptide 3 (RPS6KA3) were predicted as the most significant candidates by miRNA-mRNA network. In addition, cyclin D3 (CCND3) and clathrin heavy chain (CHC), usually up-regulated in HCC tissues, were validated as the direct target of miR-138 and miR-199a-5p, respectively. CONCLUSION: Our data suggest an importance of miR-138 and miR-199a-5p as well as their targets CCND3 and CHC in HCC tumorigenesis, and may provide more evidence for reliability of integrative bioinformatics analysis. (C) 2012 Baishideng. All rights reserved.
引用
收藏
页码:5442 / 5453
页数:12
相关论文
共 50 条
  • [31] Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma
    Diaz, Giacomo
    Melis, Marta
    Tice, Ashley
    Kleiner, David E.
    Mishra, Lopa
    Zamboni, Fausto
    Farci, Patrizia
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (04) : 816 - 824
  • [32] Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma
    Smith, MW
    Yue, ZXN
    Geiss, GK
    Sadovnikova, NY
    Carter, VS
    Boix, L
    Lazaro, CA
    Rosenberg, GB
    Bumgarner, RE
    Fausto, N
    Bruix, J
    Katze, MG
    CANCER RESEARCH, 2003, 63 (04) : 859 - 864
  • [33] Identification of miRNA and mRNA expression profiles by PCR microarray in hepatitis B virus-associated hepatocellular carcinoma
    Cui, Xiong-Wei
    Qian, Zhi-Ling
    Li, Cong
    Cui, Shi-Chang
    MOLECULAR MEDICINE REPORTS, 2018, 18 (06) : 5123 - 5132
  • [34] Identification of potential key genes and pathways in hepatitis B virus-associated hepatocellular carcinoma by bioinformatics analyses
    Zhang, Xiang
    Wang, Lingchen
    Yan, Yehong
    ONCOLOGY LETTERS, 2020, 19 (05) : 3477 - 3486
  • [35] Identification of hub genes and pathways in hepatitis B virus-associated hepatocellular carcinoma: A comprehensive in silico study
    Kalaki, Niloufar Sadat
    Ahmadzadeh, Mozhgan
    Mansouri, Atena
    Saberiyan, Mohammadreza
    Niya, Mohammad Hadi Karbalaie
    HEALTH SCIENCE REPORTS, 2024, 7 (06)
  • [36] HLA Zygosity Increases Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma
    Liu, Zhiwei
    Huang, Chih-Jen
    Huang, Yu-Han
    Pan, Mei-Hung
    Lee, Mei-Hsuan
    Yu, Kelly J.
    Pfeiffer, Ruth M.
    Viard, Mathias
    Yuki, Yuko
    Gao, Xiaojiang
    Carrington, Mary
    Chen, Chien-Jen
    Hildesheim, Allan
    Yang, Hwai-, I
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (10): : 1796 - 1805
  • [37] Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV
    Maponga, Tongai Gibson
    Glashoff, Richard H.
    Vermeulen, Hannali
    Robertson, Barbara
    Burmeister, Sean
    Bernon, Marc
    Omoshoro-Jones, Jones
    Ruff, Paul
    Neugut, Alfred, I
    Jacobson, Judith S.
    Preiser, Wolfgang
    Andersson, Monique, I
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [38] Silent hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma in Japan.
    Momosaki, S
    Hsia, C
    Nakashima, Y
    Kojiro, M
    Tabor, E
    HEPATOLOGY, 1999, 30 (04) : 637A - 637A
  • [39] HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma
    Momosaki, S
    Nakashima, Y
    Kojiro, M
    Tabor, E
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (03) : 325 - 329
  • [40] Tackling hepatitis B virus-associated hepatocellular carcinoma-the future is now
    Bharadwaj, Mausumi
    Roy, Gaurav
    Dutta, Koushik
    Misbah, Mohammad
    Husain, Mohammad
    Hussain, Showket
    CANCER AND METASTASIS REVIEWS, 2013, 32 (1-2) : 229 - 268